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No mortality n (%) p value
TIMIO--l T1M12 TIMI3 TIMI2 vs 3
TAMI1-7' 1229 34 (10.1) 13 (61) 29(4.3) NS
Vogt"'* 907 16 ( 7.1) 8 (66) 15 (27) <0.01
GUSTO 1167 34( 8.91 25 (7.4) 19 (4.41 0.08
PDoled (%) 3601 8.9**· 6.S··· 3.7 0.001
Conventionally, infarct-related arteries (IRA}with TIMI grade 0 and 1flow have
been considered as occluded and those with TIM I grade of 2 or 3 as patent.
This view has been challenged in several recent post myocardial infarction
(MI). post thrombolysis, angiographic studies indicating different clinical out-
come in patients with TIMI grade 2 flow compared to TIMI grade 3. To deter-
mine the validity of this concept we pooled the results of 12 different studies
involving 3303 patients following MI where TIMI grade flows 90 minutes af-
ter initiation of thrombolytic therapy and mortality (up to 30 days post MI)
were recorded.
'TAMI results represent acompDsite Df results from TAMil to 7 trials and "Vogt et al a
cDmpDsite Df fDur different German trials, "'TIMI 0-1 vs TIMI 2, P ~ 0.1
Conclusion; TIM I grade 3 flow IRA at 90 minute following initiation of
thrombolytic therapy is associated with 46% (odds ratio 0.52-95% CI: 0.35-
0.78) reduction in mortality compared to TIMI grade 2 flow. Patients with
TIMI grade 2 flow IRAs have similar outcome to those with TIMI grade 0 or
1. Therefore IRAs with TIMI grade 2 flow should be considered occluded
and designated as reperfusion failure rather than success. In order to im-
prove mortality post MI. it is important that new thrombolytic strategies aim
to achieve early complete and sustained (TIMI grade 3 flow) IRA patency.
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Does Primary Angioplasty Improve the
Prognosis of Patients with Diabetes and Acute
Myocardial Infarction?
Gregg W. StDne, Cindy L. Grines, Kevin F. Browne, Jean Marco, Donald Rothbaum,
James O'Keefe, GeDffrey O. Hartzler, Paul Overlie, Brian DonDhue, Noah Chelliah,
Sylvia Puchrowicz, William W. O'Neill. EI Camino Hospital, Mountain View; CA;
William Beaumont Hospital, Royal Oak, MI
To examine the effect of different reperfusion modalities in pts with DM, the
multicenter PAMI database was analyzed, in which 395 pts within 12 hours
onset of acute MI were prospectively randomized to treatment with t-PA (n =
200) vs. primary PTCA (n = 195). DM was present in 50 (13%) pts. Compared
to pts without DM, pts with DM were older (65 vs. 59 yrs, p = 0.002), more
often female (40% vs. 25%, p = 0.03), mOre frequently had HTN (68% vs.
39%, P = 0.0001), prior CHF (8% vs. 1%, P = 0.0001). multivessel disease
(76% vs. 51 %, P = 0.01) and presented later (3.8 vs. 3.0 hours, p = 0.03).
In-hospital mortality was 10.0% in pts with DM vs. 3.B% in pts without
DM (p < 0.05). By multivariate analysis of 16 variables, however, advanced
age and treatment by PTCA rather than t-PA, but not DM correlated with
in-hospital mortality.
Mortality stratified by treatment appears in the graph. Despite the appar-
ently improved prognosis of pts with DM treated with PTCA vs. t-PA. the p
value forthe x2 test for interaction effect between DM and treatment modal-
ity was 0.86; most of the benefit of PTCA was present in the elderly popula-
tion.
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In conclusion: Pts with DM and acute MI have increased mortality, primar-
ily because of advanced age. The outcome after PTCA compared to t-PA is
improved in DM largely because of PTCA's beneficial effect in the elderly.
Coronary Flow Velocity of Infarct-Related
Arteries: Physiologic Differences Between
Complete (TIMIIII) and Incomplete (TIMI 0, I, II)
Anglographic Coronary Perfusion
Frank V. Aguirre, Thomas J. Donohue, Richard G. Bach, Eugene A. Caracciolo,
Joseph A. Moore, Thomas Wolford, Alexander Khoury, Carol Mechem, Morton
J. Kern. St. Louis University. 51. Louis, MO
Infarct artery perfusion, defined by TIMI grade angiographic flow has been
demonstrated to correlate with post-infarction clinical outcome. In an at-
tempt to define physiologic differences between complete (ie, TIMI III) and
incomplete (ie, TIMI 0, I, II) angiographic grades of flow, we evaluated the
proximal (n = 19) and distal (n = 451 coronary flow velocity (CFV) of the
infarct-related artery (IRA) in 29 acute myocardial infarct patients (23 male, 6
female) before and after direct (n = 26) or rescue (n = 3) PTCA. CFV was as-
sessed proximal and distal to the IRA lesion using a 0.014" Doppler-tipped
guidewire. The mean time from symptom onset to coronary angiography
was 84 ± 7 hrs. The IRA was the LAD (n = 18). RCA (n = 7L circumflex (n =
4).
TIMI Grade Average Peak Velocity (cm/sec)
(n) Proximal (n) Post-Stenotic
0--11 (9) 19.7 ± 9.5 (21) 125 ± 7.6'
III (101 27.4 ± , 1.3 (24) 21.1 ± 12.4
Ronald D. Gregor, Iqbal R. Bata, B. RDSS MacKenzie, Pentti M. Rautaharju,
Hermann K. WDlf. Dalhousie University. Halifax NS, Canada
The purpose of this study was to determine if established recommendations
for treatment after myocardial infarction have entered clinical practice. The
Halifax MONICA database was used for this study. It contains clinical and
treatment information on all acute myocardial infarctions (AMI) in patients,
aged 25 to 74, in a defined community. The data are obtained from chart re-
views and standardized criteria are used to establish the diagnosis of AMI.
The treatment pattern of hospital-based physicians (HP) was assessed by
the frequency of major cardiac meditations prescribed at discharge of AMI
patients. The treatment pattern of family physicians (FP) was estimated by
comparing the medication profile at discharge with that on a subsequent re-
admission. There were 2827 patients discharged with a diagnosis of AMI.
Discharge medication was not recorded on 182 charts (6.4%). For the re-
maining cases a major change in prescribing pattern occurred during the
observation period. The use of aspirin IASA) rose from 16% to 78%, ACE
inhibitors (ACEi) increased from 3% to 21 %, ,8-blockers (,8B) had decreased
from 49% to 41 % but then rose to 60%. On the other hand, Ca antagonists
(CaA) rose from 25% to 50% and then declined to 36%. In 1011 patients
with re-admission, family physicians had not altered the prescription in 77%
for ASA, 84% for ACEi, 75% for {JB, and 77% for CaA. When changes were
made, addition outweighed removal for ACEi and CaA, while the opposite
happened with ASA and ,8B. There was a marginally significant decrease in
post-discharge 6-months mortality from 7.1 % to 4.3% during the observa-
tion period (p = 0.04). We conclude that post-MI prescribing of HP follows
closely the publication of major clinical trials and precedes the publication
of professional recommendations. FP generally followed the discharge pre-
scriptions, showing similar preferences for additional medication as HP. The
change in prescribing pattern may have contributed to the decreased post-
discharge mortality
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'p < 0.008 vs prDximal and distal grade III
There were no differences in post-stenotic CFV between TIMI grade 0, I
and II. Thus, distinct differences in CFV are observed in IRAs according to pre-
viously defined clinically important angiographic perfusion grades (ie, ~II vs
III). The higher distal CFVs observed among patients with angiographic "com-
plete" compared to those with "incomplete" perfusion may partially explain
their enhanced clinical outcome.
Outcome of Different Reperfusion Strategies in
Thrombolytic "Eligible" versus "Ineligible"
Patients with Acute Myocardial Infarction
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Pts considered "not eligible" for inclusion in most early U.S. thrombolytic
trials because of advanced age, late presentation, prior CABG or shock have
avery poor prognosis; thus, some have suggested broadening the criteria for
lyric eligibility. To examine the role of different reperfusion strategies In pts
